A new home care provider has officially opened its doors in Andover, marked by a celebratory coffee morning and ...

CVS faces pressures from rising medical costs, but promising guidance, stable finances, and low valuations suggest strong ...

CVS Health is a BUY. Undervalued with growth potential, it outshines competitors despite sector challenges. See more on CVS ...

The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers (PBMs) over insulin pricing practices will ...

The FTC chair had previously been recused from the lawsuit. But after consulting with ethics lawyers, Ferguson changed his ...

FTC Chair Andrew Ferguson is no longer recusing himself from the matter, he said two days after a leadership shakeup at the ...

Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this ...

The FTC says it doesn’t have enough active commissioners to move forward after President Donald Trump fired two Democrats ...

The Trump administration has paused the Federal Trade Commission's lawsuit against major pharmacy benefit managers after two ...

This week, the Federal Trade Commission halted its lawsuit against pharmacy-benefit managers CVS Caremark (CVS), Express Scripts (CI), and ...

President Donald Trump last month fired FTC Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, the only two members ...

CVS Health's pharmacy benefit manager, Caremark, is bringing Omada Health on board to be a part of its weight management ...